Pro Medicus Limited (ASX:PME)

Pro Medicus Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 21, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	17,168	21,252	29,780	14,960	6,855	4,406
Market Cap Growth	-47.57%	-28.64%	99.07%	118.24%	55.58%	-28.00%
Enterprise Value	16,918	21,033	29,600	14,830	6,763	4,332
Last Close Price	164.33	203.00	283.40	142.08	64.83	41.55

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 21, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	64.80	80.09	258.47	180.69	113.03	99.14
Forward PE	90.02	120.09	203.41	151.89	100.34	82.65
PS Ratio	65.60	81.21	139.83	92.63	54.88	47.14
PB Ratio	38.07	47.13	115.89	79.69	49.40	43.31
P/TBV Ratio	40.03	49.56	126.08	89.23	58.38	55.46
P/FCF Ratio	135.13	167.29	268.55	183.17	110.14	71.83
P/OCF Ratio	134.66	166.71	267.49	182.49	109.62	71.55
PEG Ratio	3.70	3.25	4.74	4.67	3.55	2.54

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 21, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	64.65	80.38	138.98	91.83	54.15	46.35
EV/EBITDA Ratio	85.77	107.05	187.32	131.80	80.16	70.34
EV/EBIT Ratio	86.26	107.25	187.71	132.11	80.43	70.66
EV/FCF Ratio	133.17	165.56	266.92	181.58	108.66	70.63

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 21, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.01	0.01	0.02	0.02	0.04
Debt / FCF Ratio	0.02	0.02	0.02	0.03	0.03	0.04
Net Debt / Equity Ratio	-0.56	-0.56	-0.81	-0.82	-0.86	-0.87
Net Debt / EBITDA Ratio	-1.27	-1.27	-1.32	-1.36	-1.42	-1.43
Net Debt / FCF Ratio	-1.97	-1.97	-1.88	-1.88	-1.92	-1.44
Asset Turnover	0.55	0.55	0.72	0.70	0.70	0.66
Inventory Turnover	-	-	-	5.79	8.24	8.38
Quick Ratio	6.75	6.75	6.38	5.90	5.24	4.39
Current Ratio	6.85	6.85	6.49	5.98	5.31	4.46
Return on Equity (ROE)	74.97%	74.97%	51.82%	50.71%	50.43%	48.46%
Return on Assets (ROA)	25.84%	25.84%	33.06%	30.53%	29.26%	27.12%
Return on Invested Capital (ROIC)	68.62%	110.53%	268.28%	298.21%	363.36%	240.38%
Return on Capital Employed (ROCE)	35.20%	35.20%	53.40%	50.40%	49.10%	47.10%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 21, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	1.55%	1.25%	0.39%	0.55%	0.89%	1.01%
FCF Yield	0.74%	0.60%	0.37%	0.55%	0.91%	1.39%
Dividend Yield	0.45%	0.34%	0.19%	0.28%	0.46%	0.53%
Payout Ratio	24.41%	24.41%	42.63%	44.15%	43.05%	42.27%
Buyback Yield / Dilution	0.01%	0.01%	-0.01%	-0.06%	-0.01%	0.01%
Total Shareholder Return	0.46%	0.35%	0.18%	0.22%	0.46%	0.54%

Data Source: S&P Global Market Intelligence Last updated: Aug 18, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 19, 2026

Data Sources Report a data error